Use of lacosamide in children: experience of a tertiary medical care center in Brazil

Use of lacosamide in children: experience of a tertiary medical care center in Brazil

Background Lacosamide (LCM) is a third-generation anti-seizure drug approved in Europe and the United States, either as a monotherapy or adjunctive therapy, to treat partial-onset seizures in adults, adolescents, and children. In Brazil, LCM is licensed for treatment only in patients older than 16 y...

Full description

Bibliographic Details
Main Authors: Tayla Taynan Romão, Abraão Iuri Medeiros Angelim, Henrique Jannuzzelli Pires do Prado, Fernanda Veiga de Goes, Maria Elisa Paiva Pires, Rosiane da Silva Fontana, Lais de Carvalho Pires, Alexandre Ribeiro Fernandes, Isabella D'Andrea-Meira
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO) 2022-11-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
epilepsy
lacosamide
child
drug resistant epilepsy
pediatric assistants
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1758366

Similar Items

Similar Items